Capricor Therapeutics | CAPR - Interest Expense On Debt


Capricor Therapeutics reported 3.05M in Interest Expense on Debt for its fiscal quarter ending in December of 2025.





Interest Expense On Debt Change Date
Bioline Rx USD 280K 80K Dec/2025
Capricor Therapeutics 3.05M 2.46M Dec/2025
Cipla INR 167.4M 2.9M Sep/2026
Cytokinetics USD 38.48M 3.65M Sep/2026
Geron USD 7.21M 61K Sep/2026
Grifols EUR 156.07M 31.46M Sep/2025
Immunic 197K 222K Dec/2025
J&J USD 43M 25M Mar/2026
Plus Therapeutics USD 62K 25K Dec/2023
Prothena USD 283.52M 19.06M Sep/2026
PTC Therapeutics USD 3.21B 42.76M Sep/2026
Sarepta Therapeutics USD 21.51M 205K Jun/2026